These effects, together with a previous report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like habits in mice,2 help the concept of targeting ACKR3 as a unique approach to modulate the opioid procedure, which could open up new therapeutic avenues for opioid-linked Problems. Disclaimer: The above is a https://piersj394brh9.59bloggers.com/profile